Nadav Kidron Oramed Pharmaceuticals Inc. (ORMP) insider trading activity
Nadav Kidron is President and CEO of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 1.78 Million shares of ORMP, which is worth approximately $4.13 Million. The most recent transaction as insider was on Jan 04, 2024, when has been sold 329,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.78M
0%
3M change
22.66%
12M change
Total Value Held
$4.13 Million
NADAV KIDRON Transaction History
NK
Nadav Kidron
President and CEO
New York, NY